ID

23147

Description

Clinical Trial of Recombinant Hepatitis E Vaccine; ODM derived from: https://clinicaltrials.gov/show/NCT01014845

Link

https://clinicaltrials.gov/show/NCT01014845

Keywords

  1. 6/26/17 6/26/17 -
Uploaded on

June 26, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatitis E NCT01014845

Eligibility Hepatitis E NCT01014845

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
healthy people aged from 16 years to 65 years old at the time of the first vaccination, normal intelligence and agree to sign the informed consent form.
Description

ID.1

Data type

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0424576
UMLS CUI [1,3]
C1168057
UMLS CUI [1,4]
C0021430
subjects will reside in the study region in the next 19 months.
Description

ID.2

Data type

boolean

Alias
UMLS CUI [1]
C1550511
free of history of hepatitis b or hepatitis e.
Description

ID.3

Data type

boolean

Alias
UMLS CUI [1,1]
C0332122
UMLS CUI [1,2]
C0019163
UMLS CUI [1,3]
C0085293
can comply with the request of study.
Description

ID.4

Data type

boolean

Alias
UMLS CUI [1]
C1321605
axillary temperature is below 37 degree centigrade.
Description

ID.5

Data type

boolean

Alias
UMLS CUI [1]
C1531924
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
having other vaccine or immunoglobulin within two weeks;
Description

ID.7

Data type

boolean

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C0021027
having allergic history to vaccine and medicine
Description

ID.8

Data type

boolean

Alias
UMLS CUI [1]
C0571550
eclampsia, epilepsy, encephalopathy and history of mental disease or family;
Description

ID.9

Data type

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0013537
UMLS CUI [1,3]
C0014544
UMLS CUI [1,4]
C0085584
thrombocytopenia or other disturbance of blood coagulation which would lead to muscle injection taboo;
Description

ID.10

Data type

boolean

Alias
UMLS CUI [1,1]
C0040034
UMLS CUI [1,2]
C0005779
fixed or suspected deficiency of immunologic function, containing immunosuppressant treatment(radiation therapy, chemical treatment, steroid hormone, antimetabolites, cytotoxic drugs), genetic defect(e.g. fabism), hiv or other factors;
Description

ID.11

Data type

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C0021051
congenital malformation, eccyliosis or severe chronic disease(e.g. down syndrome, diabetes, sickle cell anemia or mental disease);
Description

ID.12

Data type

boolean

Alias
UMLS CUI [1]
C0012634
fixed or suspected other disease including fever, active infection, liver and kidney disease, angiocardiopathy, malignancy, acute and chronic disease;
Description

ID.13

Data type

boolean

Alias
UMLS CUI [1]
C0012634
joining other clinical study undergoing;
Description

ID.14

Data type

boolean

Alias
UMLS CUI [1]
C0008976
women pregnant or in lactation.
Description

ID.15

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
severe allergy for dose 1 or 2;
Description

ID.17

Data type

boolean

Alias
UMLS CUI [1]
C0020517
severe adverse reaction associated with last vaccination;
Description

ID.18

Data type

boolean

Alias
UMLS CUI [1,1]
C0559546
UMLS CUI [1,2]
C0042196

Similar models

Eligibility Hepatitis E NCT01014845

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
healthy people aged from 16 years to 65 years old at the time of the first vaccination, normal intelligence and agree to sign the informed consent form.
boolean
C0001779 (UMLS CUI [1,1])
C0424576 (UMLS CUI [1,2])
C1168057 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,4])
ID.2
Item
subjects will reside in the study region in the next 19 months.
boolean
C1550511 (UMLS CUI [1])
ID.3
Item
free of history of hepatitis b or hepatitis e.
boolean
C0332122 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0085293 (UMLS CUI [1,3])
ID.4
Item
can comply with the request of study.
boolean
C1321605 (UMLS CUI [1])
ID.5
Item
axillary temperature is below 37 degree centigrade.
boolean
C1531924 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.7
Item
having other vaccine or immunoglobulin within two weeks;
boolean
C0042196 (UMLS CUI [1,1])
C0021027 (UMLS CUI [1,2])
ID.8
Item
having allergic history to vaccine and medicine
boolean
C0571550 (UMLS CUI [1])
ID.9
Item
eclampsia, epilepsy, encephalopathy and history of mental disease or family;
boolean
C0004936 (UMLS CUI [1,1])
C0013537 (UMLS CUI [1,2])
C0014544 (UMLS CUI [1,3])
C0085584 (UMLS CUI [1,4])
ID.10
Item
thrombocytopenia or other disturbance of blood coagulation which would lead to muscle injection taboo;
boolean
C0040034 (UMLS CUI [1,1])
C0005779 (UMLS CUI [1,2])
ID.11
Item
fixed or suspected deficiency of immunologic function, containing immunosuppressant treatment(radiation therapy, chemical treatment, steroid hormone, antimetabolites, cytotoxic drugs), genetic defect(e.g. fabism), hiv or other factors;
boolean
C0021081 (UMLS CUI [1,1])
C0021051 (UMLS CUI [1,2])
ID.12
Item
congenital malformation, eccyliosis or severe chronic disease(e.g. down syndrome, diabetes, sickle cell anemia or mental disease);
boolean
C0012634 (UMLS CUI [1])
ID.13
Item
fixed or suspected other disease including fever, active infection, liver and kidney disease, angiocardiopathy, malignancy, acute and chronic disease;
boolean
C0012634 (UMLS CUI [1])
ID.14
Item
joining other clinical study undergoing;
boolean
C0008976 (UMLS CUI [1])
ID.15
Item
women pregnant or in lactation.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.17
Item
severe allergy for dose 1 or 2;
boolean
C0020517 (UMLS CUI [1])
ID.18
Item
severe adverse reaction associated with last vaccination;
boolean
C0559546 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial